NCT00289601View on ClinicalTrials.gov

Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty

PHASE4TerminatedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

December 31, 2007

Conditions

Angioplasty

Interventions

DRUG

eptifibatide

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

Brigham and Women's Hospital

OTHER